Prazosin is an alpha-1 adrenergic receptor antagonist classified as an alpha-blocker, utilized in the treatment of hypertension, benign prostatic hyperplasia, and anxiety to help relax smooth muscle. This… Read more






![Chemical structure of Bicyclo[2.2.2]octa-2,5-diene-2-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F102589-30-0-Bicyclo2.2.2octa-25-diene-2-carboxylic-Acid.png&w=3840&q=75)




![Chemical structure of N1-[2-(1-Piperazinyl)ethyl]-1,2-ethanediamine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F24028-46-4-N1-2-1-Piperazinylethyl-12-ethanediamine.png&w=3840&q=75)








Prazosin is an alpha-1 adrenergic receptor antagonist classified as an alpha-blocker, utilized in the treatment of hypertension, benign prostatic hyperplasia, and anxiety to help relax smooth muscle. This category encompasses a comprehensive suite of pharmaceutical reference standards, including synthetic intermediates, degradation products, process-related impurities, and metabolic derivatives essential for rigorous quality control. Laboratories utilize these compounds to conduct precise impurity profiling, ensuring that pharmaceutical formulations meet the strict safety and regulatory benchmarks required by pharmacopeial standards. The collection includes stable isotope labelled compounds, such as deuterated variants, which act as internal standards for quantitative bioanalytical method validation and mass spectrometry-based assays. By providing access to structurally characterized related compounds and metabolites, these materials support the development of robust analytical methods and facilitate compliance with international guidelines for impurity identification throughout the pharmaceutical development lifecycle.